Last reviewed · How we verify

NCT03775733

Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Hyperglycemia

Status unknown NA Last updated 8 May 2020
What this trial tests

NA trial testing Hydrolysed Red Ginseng Extract in Hyperglycemia in 80 participants. Status unknown.

Timeline
7 September 2018
Primary endpoint
30 December 2020
31 December 2020

Quick facts

Lead sponsorChonbuk National University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment80
Start date7 September 2018
Primary completion30 December 2020
Estimated completion31 December 2020
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Chonbuk National University Hospital

Who can join

Adults 19 to 80, any sex, with Hyperglycemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to investigate the effects of daily supplementation of hydrolysed red ginseng extract on improvement of Hyperglycemia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Transfer Learning and Permutation-Invariance Improving Predicting Genome-Wide, Cell-Specific and Directional Interventions Effects of Complex Systems.
    Wang B, Pan B, Zhang T, Liu Q, et al · · 2025 · cited 4× · PMID 40971773 · DOI 10.1002/advs.202509456

Verify or expand the search:

Other trials of Hydrolysed Red Ginseng Extract

Trials testing the same drug.

Other recruiting trials for Hyperglycemia

Currently open trials in the same condition.

Other Chonbuk National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03775733.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing